| Hydrogen sulfide and nitric oxide are mutually dependent in the regulation of angiogenesis and endothelium-dependent vasorelaxation C Coletta, A Papapetropoulos, K Erdelyi, G Olah, K Módis, P Panopoulos, ... Proceedings of the National Academy of Sciences 109 (23), 9161-9166, 2012 | 705 | 2012 |
| MD-2 is required for disulfide HMGB1–dependent TLR4 signaling H Yang, H Wang, Z Ju, AA Ragab, P Lundbäck, W Long, SI Valdes-Ferrer, ... Journal of Experimental Medicine 212 (1), 5-14, 2015 | 362 | 2015 |
| Hydrogen sulfide replacement therapy protects the vascular endothelium in hyperglycemia by preserving mitochondrial function K Suzuki, G Olah, K Modis, C Coletta, G Kulp, D Gerö, P Szoleczky, ... Proceedings of the National Academy of Sciences 108 (33), 13829-13834, 2011 | 316 | 2011 |
| Cardioprotective effects of hydrogen sulfide G Szabó, G Veres, T Radovits, D Gerő, K Módis, C Miesel-Gröschel, ... Nitric Oxide 25 (2), 201-210, 2011 | 162 | 2011 |
| Significant role for Fas in the pathogenesis of autoimmune diabetes X Su, Q Hu, JM Kristan, C Costa, Y Shen, D Gero, LA Matis, Y Wang The Journal of Immunology 164 (5), 2523-2532, 2000 | 161 | 2000 |
| The novel mitochondria-targeted hydrogen sulfide (H2S) donors AP123 and AP39 protect against hyperglycemic injury in microvascular endothelial cells in vitro D Gerő, R Torregrossa, A Perry, A Waters, S Le-Trionnaire, JL Whatmore, ... Pharmacological research 113, 186-198, 2016 | 149 | 2016 |
| Mitochondrial NO and reactive nitrogen species production: does mtNOS exist? Z Lacza, E Pankotai, A Csordás, D Gero, L Kiss, EM Horváth, M Kollai, ... Nitric oxide 14 (2), 162-168, 2006 | 139 | 2006 |
| Cellular bioenergetics is regulated by PARP1 under resting conditions and during oxidative stress K Módis, D Gerő, K Erdélyi, P Szoleczky, D DeWitt, C Szabo Biochemical pharmacology 83 (5), 633-643, 2012 | 90 | 2012 |
| Screening of a composite library of clinically used drugs and well-characterized pharmacological compounds for cystathionine β-synthase inhibition identifies benserazide as a … N Druzhyna, B Szczesny, G Olah, K Módis, A Asimakopoulou, A Pavlidou, ... Pharmacological research 113, 18-37, 2016 | 68 | 2016 |
| Activation of the poly (ADP-ribose) polymerase pathway in human heart failure A Molnár, A Tóth, Z Bagi, Z Papp, I Édes, M Vaszily, Z Galajda, JG Papp, ... Molecular medicine 12, 143-152, 2006 | 66 | 2006 |
| The peroxynitrite decomposition catalyst FP15 improves ageing-associated cardiac and vascular dysfunction T Radovits, L Seres, D Gerő, L Lin, CJ Beller, SH Chen, J Zotkina, I Berger, ... Mechanisms of ageing and development 128 (2), 173-181, 2007 | 64 | 2007 |
| Activation of poly (ADP-ribose) polymerase by myocardial ischemia and coronary reperfusion in human circulating leukocytes E Tóth-Zsámboki, E Horváth, K Vargova, E Pankotai, K Murthy, ... Molecular medicine 12, 221-228, 2006 | 63 | 2006 |
| Poly (ADP-ribose) polymerase: a new therapeutic target? D Gerö, C Szabó Current Opinion in Anesthesiology 21 (2), 111-121, 2008 | 62 | 2008 |
| Single dose treatment with PARP-inhibitor INO-1001 improves aging-associated cardiac and vascular dysfunction T Radovits, L Seres, D Gerő, I Berger, C Szabó, M Karck, G Szabó Experimental gerontology 42 (7), 676-685, 2007 | 62 | 2007 |
| Poly (ADP-ribose) polymerase inhibition improves endothelial dysfunction induced by reactive oxidant hydrogen peroxide in vitro T Radovits, L Lin, J Zotkina, D Gerő, C Szabó, M Karck, G Szabó European journal of pharmacology 564 (1-3), 158-166, 2007 | 57 | 2007 |
| Effects of inosine on reperfusion injury after heart transplantation G Szabó, N Stumpf, T Radovits, K Sonnenberg, D Gerö, S Hagl, C Szabó, ... European journal of cardio-thoracic surgery 30 (1), 96-102, 2006 | 56 | 2006 |
| Differentiation-associated downregulation of poly (ADP-ribose) polymerase-1 expression in myoblasts serves to increase their resistance to oxidative stress G Oláh, B Szczesny, A Brunyánszki, IA López-García, D Gerö, Z Radák, ... PLoS One 10 (7), e0134227, 2015 | 55 | 2015 |
| Cell-based screening identifies paroxetine as an inhibitor of diabetic endothelial dysfunction D Gerö, P Szoleczky, K Suzuki, K Módis, G Oláh, C Coletta, C Szabo Diabetes 62 (3), 953-964, 2013 | 55 | 2013 |
| Cytoprotective effects of adenosine and inosine in an in vitro model of acute tubular necrosis K Módis, D Gerő, N Nagy, P Szoleczky, ZD Tóth, C Szabó British journal of pharmacology 158 (6), 1565-1578, 2009 | 55 | 2009 |
| A cell-microelectronic sensing technique for the screening of cytoprotective compounds B Ózsvári, LG Puskás, LI Nagy, I Kanizsai, M Gyuris, R Madácsi, LZ Fehér, ... International journal of molecular medicine 25 (4), 525-530, 2010 | 52 | 2010 |
